Ketamine IV for the prevention of depression in the elderly: new data

Published Date: 13 Mar 2023

Intravenous (IV) ketamine is effective in adults resistant to depression. The response was similar to that seen in younger patients, two new studies show.

Read Full News

Latest News

Giardia Cases in England at Highest Level in Almost a Decade

UKHSA data show cases rose 11.4% in 2025, with adults aged 30-39 and Londoners most affected.

Corrosion Alert for Cobalt Chrome Hip Replacements

UK regulator flags wear and corrosion risks in five cobalt-chrome hip implant systems, advising clinical review for affected patients.

The Subjective Stethoscope, Diagnosing Pneumonia in Kids

Hallmark signs of pediatric pneumonia, including crackles and decreased breath sounds, shows low reliability between clinicians examining the same patients.

Aid Group MSF Opens New Ebola Treatment Centre in Eastern Congo

French aid group Medecins Sans Frontieres said on Friday it had opened a ⁠new Ebola treatment centre in eastern Democratic Republic of Congo.

WHO Says Ebola Outbreak in Uganda Is Over, as Cases Rise in Congo

The outbreak of the Bundibugyo strain of Ebola in Uganda is over ⁠but it is not under control in neighbouring Democratic Republic of Congo, a World Health Organization...

Exercise Type Matters for Post-Stroke Mental Health

Dual-task training and mind-body exercise are most beneficial for post-stroke depression in older adults; resistance training leads for post-stroke anxiety, a study shows.

Todays Updates

Milvexian Fails to Reduce CV Events After ACS

Patients in the phase 3 LIBREXIA ACS trial showed no reduction in cardiovascular events after acute coronary syndrome.

Atorvastatin Cuts Major CV Events by 30% in Older Adults in STAREE

Statin use for primary cardiovascular prevention in adults aged 70 years or older is supported by data from STAREE, although treatment did not prolong disability-free survival.

Phase 3 Eplontersen Trial Results Disappoint

Despite a major reduction in transthyretin amyloid deposits, eplontersen, a drug that reduces TTR production, did not reduce events associated with TTR amyloidosis in a phase 3 trial.

Todays Updates

Milvexian Fails to Reduce CV Events After ACS

Patients in the phase 3 LIBREXIA ACS trial showed no reduction in cardiovascular events after acute coronary syndrome.

Atorvastatin Cuts Major CV Events by 30% in Older Adults in STAREE

Statin use for primary cardiovascular prevention in adults aged 70 years or older is supported by data from STAREE, although treatment did not prolong disability-free survival.

Phase 3 Eplontersen Trial Results Disappoint

Despite a major reduction in transthyretin amyloid deposits, eplontersen, a drug that reduces TTR production, did not reduce events associated with TTR amyloidosis in a phase 3 trial.

Latest News

UKHSA data show cases rose 11.4% in 2025, with adults aged 30-39 and Londoners most affected.

UK regulator flags wear and corrosion risks in five cobalt-chrome hip implant systems, advising clinical review for affected patients.

Hallmark signs of pediatric pneumonia, including crackles and decreased breath sounds, shows low reliability between clinicians examining the same patients.

French aid group Medecins Sans Frontieres said on Friday it had opened a ⁠new Ebola treatment centre in eastern Democratic Republic of Congo.

The outbreak of the Bundibugyo strain of Ebola in Uganda is over ⁠but it is not under control in neighbouring Democratic Republic of Congo, a World Health Organization...

Dual-task training and mind-body exercise are most beneficial for post-stroke depression in older adults; resistance training leads for post-stroke anxiety, a study shows.

News All Time

NFL-At Least One in Four Former Players Who Died Between 2016 and 2021 Had CTE, Study Shows

(removes hyphens in headline, no change to story)

His Hiccups Signaled a Life-Threatening Problem

Team says case is a reminder not to trivialize persistent hiccups when accompanied by coughing

'The Pitt' Actors Get Over a Dozen Emmy Nominations

Last year, the show got just three acting nominations (and three wins)

I Survived an Earthquake. Here's What to Know Following Venezuela's Disaster.

Sleep is one of the most consistent, measurable, and modifiable signals of trauma exposure

'A Big, Black Hole': Katie Couric Opens Up About the Day Her Memory Vanished

What is transient global amnesia? Couric's recent health scare explained

Cyclosporiasis Cases Rise; Quarantine Trauma Revealed; ER Doctor Saved by Team

Health news and commentary gathered by MedPage Today staff

Aortic Dissection: What to Know About Lindsey Graham's Death

Painful event can cause internal bleeding, block the flow of blood from the heart to other organs

Declaring Death Is Not So Simple

A recent case in Arizona brought this issue to the fore

Trump Administration Demands Hospitals Share Emergency Department Records

At least 100 hospitals have been asked to send identifiable medical records for all visits

AMA President: It's Time to Lift Limits on Physician-Owned Hospitals

Easing restrictions can increase innovation, competition, and access to care

Restrictions on Physician-Owned Hospitals are Justified

Safeguards help prevent cherry-picking and ensure hospitals can serve all patients

U.S. Sees Big Jump in Nausea Cases Among Frequent Marijuana Users in the Hospital

New diagnostic coding may provide a more accurate picture

Massachusetts Close to Giving Doctors Final Say on Whether to Perform Late Abortions

Measure is on its way to the governor after being adopted by the state Senate

'The Pitt' Season 3: Noah Wyle Shares Details

Hints at main character's mental state upon returning from sabbatical

I'm an Emergency Physician, and I'm Ready to Start Prescribing Air Conditioning

Cooling is healthcare

Rural Emergency Medicine Should be an Aspiration, Not a Back Up Plan

— It takes grit to do what we do

Recommended News For You

Testicular Mass Serendipitously Found 12 Years After Prostate Cancer Dx

Adult survivors of childhood cancer are at high risk for cognitive impairment, according to JAMA.

Retifanlimab-Chemo Combo Boosts PFS in Advanced Squamous Cell Anal Cancer

How breast tissue density affects your risk of breast cancer

Rectal Cancer 'Crisis'; Smells Like Cancer; Flushing Away Clues to Colon Cancer

A small rise in cancer was observed following the 1986 Chernobyl accident.

An Eye Surgeon's Unexpected Discovery of the "Before and After".

Recommended Articles For You

The Surprising Role of Magnesium in Digestion, Sleep and Mental Health  

Insights into Doxorubicin and Liposomal Doxorubicin in Extra-Abdominal Desmoid-Type Fibromatosis 

A Comprehensive Guide to Carcinoma in Situ: Types, Risks, and Preventive Measures 

Tumor Microenvironment Readiness as a Predictor of Cancer Progression 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Laryngeal Transplant Helped a Cancer Patient Speak Again in Pioneering Study

2.

New methods show how fast breast cancers grow and how surgery delays affect cancer staging

3.

Some low-grade prostate cancers carry higher risks than biopsy suggests

4.

Dostarlimab Boosts Long-Term Survival in Endometrial Cancer

5.

Avoiding Neuropathy From Chemo; Predictive Value of Screening EKGs

1.

Unraveling the Mysteries of Hematocrit: How It Impacts Your Health

2.

Revolutionizing Cancer Treatment: Advances in Immunotherapy and Cell Therapy

3.

Clinical Pharmacology of Erythroid Maturation Pathway Regulators

4.

Precision Medicine for Bone Marrow Microenvironment Remodeling

5.

Everything You Need to Know About HTLV: A Comprehensive Guide 

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

"Lorlatinib Upfront": A Niche but Powerful Option For ALK+ NSCLC

2.

A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months

3.

Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC

4.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot